DUBLIN–(BUSINESS WIRE)–The “eClinical Solutions Market Size, Share & Trends Analysis Report by Product (eCOA, CTMS, EDC & CDMS), by Delivery Mode (Web-hosted, Licensed Enterprise, Cloud-based), by Development Phase, by End Use, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.
The global eClinical solutions market size is expected to reach USD 21.8 billion by 2030. The market is expected to expand at a CAGR of 13.6% from 2022 to 2030. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth.
During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage the huge influx of specimens daily. Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years.
As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development processes are poised to boost market growth over the forecast period. Moreover, digital transformation in the field of clinical trials and preference for data-centric approaches are providing a tremendous push to the market.
Demand for integrated clinical IT solutions is increasing due to the massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and by reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.
Increasing adoption of eClinical workflows in trials offers enormous potential in clinical development processes. These solutions can facilitate decision-making in each stage of development. It also helps reduce cost and time between the development phase by utilizing seamless designs and by identifying failing compounds. In addition, it offers rapid access to data and patient safety information, which helps make quick decisions.
Market players engage in new product development and strategic alliances including partnership agreements, promotional activities, and acquisitions to keep market rivalry high. For instance, in October 2020, Oracle entered into collaboration with FHI Clinical Inc. for improving clinical trial efficiency and to get therapies to market faster.
eClinical Solutions Market Report Highlights
- CTMS led the product segment in 2021 and accounted for a revenue share of around 21% owing to benefits of the product such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
- The cloud-based systems segment is anticipated to exhibit an exponential CAGR of 15.1% during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup. Real-time data is available through these systems, which enables users to take quick decisions and provide high-quality information for risk-based monitoring
- The CROs segment held the largest revenue share in the market in 2021. The segment is projected to rise at a remarkable CAGR of 13.9% during the forecast period owing to the growing inclination of pharmaceutical companies to reduce overall expenditure
- Key companies engage in various business strategies such as mergers and acquisitions and new product development to gain greater market share
Companies Mentioned
- Oracle
- PAREXEL International Corporation
- Medidata Solution, Inc.
- Bioclinica
- DATATRAK International, Inc.
- CRF Health
- ERT Clinical
- eClinicalWorks
- IBM Watson Health
- OmniComm Systems, Inc. (Anju Software Inc.)
- eClinical Solutions
- Veeva Systems
Key Topics Covered:
Chapter 1. Research Methodology & Scope
Chapter 2. Executive Summary
Chapter 3. eClinical Solution Market Variables Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping By Delivery Mode, 2021
3.3 Pricing Analysis
3.3.1 By Product
3.3.1.1 eCOA
3.3.1.2 EDC & CDMS
3.3.1.3 Clinical Analytics Platforms
3.3.1.4 Clinical data integration platforms
3.3.1.5 Safety solutions
3.3.1.6 CTMS
3.3.1.7 RTSM
3.3.1.8 eTMF
3.3.2 By Delivery mode
3.3.3 by Development phase
3.4 User Perspective Analysis
3.4.1 Market influencer analysis
3.5 List of Key End Users
3.6 Technology Overview
3.7 Regulatory Framework
3.8 Market Dynamics
3.8.1 Market Driver Analysis
3.8.1.1 Increasing externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies
3.8.1.2 Advantages of eClinical solutions
3.8.1.3 Presence of a strong range of products in the pipeline
3.8.2 Market Restraints Analysis
3.8.2.1 Scarcity of skilled research professionals
3.8.2.2 Lack of recognition
3.8.3 Industry challenges
3.9 Industry Analysis – Porter’s
3.10 eClinical Solutions – SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
Chapter 4. COVID-19 Impact Analysis
4.1 COVID-19 Outbreak
4.2 Impact on Ongoing Clinical Trials
4.2.1 Obstacles in clinical trials:
4.2.2 Disrupted clinical trials
4.3 Demand Analysis
4.3.1 Product Pipeline Analysis, by Stage for COVID-19
4.4 Virtual Clinical Trials
4.5 Recent Developments & Strategic Outcomes
4.5.1 Strategies implemented by companies
Chapter 5. eClinical Solutions Market: Competitive Analysis
5.1 Market Participation Categorization
5.2 Public Companies
5.2.1 Company market position analysis
5.3 Company Market Share Analysis
5.3.1 eClinical solutions estimated company market share analysis, 2021
5.4 Competitive & Vendor Landscape
5.4.1 List of key strategies, by company
5.4.2 Market leader
5.4.3 Innovators
5.4.4 Vendor Landscape
Chapter 6. eClinical Solutions Market: Product Analysis
6.1 Product Business Analysis
6.1.1 Electronic clinical outcome assessment (ECOA)
6.1.2 Electronic data capture (EDC) & clinical data management systems (CDMS)
6.1.3 Clinical analytics platform
6.1.4 Clinical data integration platform
6.1.5 Safety solutions
6.1.6 Clinical trial management systems (CTMS)
6.1.7 Randomization and trial supply management (RTSM)
6.1.8 Electronic trial master file (eTMF)
Chapter 7. eClinical Solutions Market: Delivery Mode Analysis
7.1 Delivery Mode Business Analysis
7.1.1 Web-hosted
7.1.3 Licensed Enterprise
7.1.5 Cloud-based
Chapter 8. eClinical Solutions Market: Development Phase Analysis
8.1 Development Phase Business Analysis
8.2 Phase I
8.3 Phase III
Chapter 9. eClinical Solutions Market: End-use Analysis
9.1 End-use Business Analysis
9.2 Hospitals/Healthcare Providers
9.3. Academic institutes
9.4 Pharma & biotech organizations
9.5 Medical device manufacturers
Chapter 10. eClinical Solutions Market: Regional Market Analysis, By Product, 2017 – 2030 (USD Million)
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2021& 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 Regional Market Share and Leading Players, 2021
10.6 Market Size, & Forecasts, and Trend Analysis, 2017 to 2030
Chapter 11. Company Profiles
Chapter 12. Recommendations/Conclusion
For more information about this report visit https://www.researchandmarkets.com/r/8moy6e
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900